In addition, high densities of activated TIL-Bs together with low densities of Tregs (FoxP3+/CD4+) in NSCLC tumors have consistently been associated with a better clinical outcome [67,68,69]. Here, FOXP3 is linked to non-small cell lung carcinoma.